These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 31511292)

  • 1. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 12 immunosuppressive agents for idiopathic membranous nephropathy in adults: A pairwise and network meta-analysis.
    Liu J; Li X; Huang T; Xu G
    Front Pharmacol; 2022; 13():917532. PubMed ID: 35959430
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.
    Xie G; Xu J; Ye C; Chen D; Xu C; Yang L; Ma Y; Hu X; Li L; Sun L; Zhao X; Mao Z; Mei C
    PLoS One; 2012; 7(9):e44330. PubMed ID: 22957065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus versus cyclophosphamide for patients with idiopathic membranous nephropathy and treated with steroids: a systematic review and meta-analysis of randomized controlled trials.
    Huang H; Liang Z; Zheng X; Qing Q; Du X; Tang Z; Wei M; Wang C; Zhong Q; Lin X
    Ren Fail; 2021 Dec; 43(1):840-850. PubMed ID: 34016023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tacrolimus monotherapy versus cyclophosphamide-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Jul; 100(28):e26628. PubMed ID: 34260552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and cost of different treatment in patients with idiopathic membranous nephropathy: A network meta-analysis and cost-effectiveness analysis.
    Dai P; Xie W; Yu X; Sun J; Wang S; Kawuki J
    Int Immunopharmacol; 2021 May; 94():107376. PubMed ID: 33582591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
    Qiu TT; Zhang C; Zhao HW; Zhou JW
    Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cyclosporine A in the treatment of idiopathic membranous nephropathy in an Asian population.
    Lin S; Li HY; Zhou T; Lin W
    Drug Des Devel Ther; 2019; 13():2305-2330. PubMed ID: 31371924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cyclophosphamide versus tacrolimus in terms of treatment effect for idiopathic membranous nephropathy: A meta-analysis.
    Li YC; Huang J; Li X; Zhao SM
    Nefrologia (Engl Ed); 2019; 39(3):269-276. PubMed ID: 30755327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy.
    Shang SL; Cai GY; Duan SW; Li P; Li QG; Chen XM
    BMC Nephrol; 2018 Jul; 19(1):182. PubMed ID: 30021637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.
    Gong L; Xu M; Xu W; Tang W; Lu J; Jiang W; Xie F; Ding L; Qian X
    Medicine (Baltimore); 2021 Dec; 100(51):e28225. PubMed ID: 34941086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low or heavy rituximab‑based protocols and comparison with seven regimens in idiopathic membranous nephropathy: a systematic review and network meta-analysis.
    Chen M; Zhang X; Xiong Y; Xu G
    Int Urol Nephrol; 2023 Mar; 55(3):641-651. PubMed ID: 36161550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.